1. Home
  2. SPTX vs UPBD Comparison

SPTX vs UPBD Comparison

Compare SPTX & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$20.57

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo Upbound Group Inc.

UPBD

Upbound Group Inc.

HOLD

Current Price

$19.87

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPTX
UPBD
Founded
N/A
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2026
1996

Fundamental Metrics

Financial Performance
Metric
SPTX
UPBD
Price
$20.57
$19.87
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$32.25
AVG Volume (30 Days)
93.1K
1.1M
Earning Date
N/A
04-30-2026
Dividend Yield
N/A
8.25%
EPS Growth
N/A
N/A
EPS
N/A
0.98
Revenue
N/A
$4,695,061,000.00
Revenue This Year
N/A
$5.96
Revenue Next Year
N/A
$6.47
P/E Ratio
N/A
$19.79
Revenue Growth
N/A
8.67
52 Week Low
$17.59
$15.82
52 Week High
$22.98
$28.03

Technical Indicators

Market Signals
Indicator
SPTX
UPBD
Relative Strength Index (RSI) 50.62 45.16
Support Level $18.72 $16.88
Resistance Level $22.42 $21.16
Average True Range (ATR) 1.41 0.90
MACD -0.17 -0.29
Stochastic Oscillator 24.21 22.86

Price Performance

Historical Comparison
SPTX
UPBD

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has four operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions, Mexico segment offers lease-to-own stores in Mexico. The The Brigit segment offers various financial health products and tools to help users improve their financial health. The company derives a majority of its revenue from the Acima segment.

Share on Social Networks: